Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 6/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.39 |
| ▸ | CETP | P11597 | 1/20 | 0.39 |
| ▸ | RBP4 | P02753 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | CSF1R | P07333 | 1/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.38 |
| ▸ | KIT | P10721 | 1/20 | 0.38 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7672577 | 0.92 | SMN1; SMN2 (0.46) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6 | |
| SCHEMBL22589355 | 0.92 | SMN1; SMN2 (0.49) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6 | |
| SCHEMBL7679543 | 0.91 | SMN1; SMN2 (0.43) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6 | |
| SCHEMBL5725923 | 0.85 | SMN1; SMN2 (0.51) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6 | |
| SCHEMBL22589283 | 0.82 | CHRM2 (0.51) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6 | |
| SCHEMBL7467972 | 0.78 | SMN1; SMN2 (0.41) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6 | |
| SCHEMBL5117324 | 0.77 | SMN1; SMN2 (0.43) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6 | |
| SCHEMBL5117318 | 0.77 | SMN1; SMN2 (0.43) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6 | |
| SCHEMBL3099573 | 0.75 | CHRM2 (0.54) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2C19 | |
| SCHEMBL5104915 | 0.73 | SMN1; SMN2 (0.43) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0863757-B1 | 2-SUBSTITUTED ARYL PYRROLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE | MERCK & CO INC (US) | 2003-03-26 | — | — | EP | disclosed |
| EP-1131314-A4 | COMPOUNDS HAVING CYTOKINE INHIBITORY ACTIVITY | MERCK & CO INC (US) | 2002-05-02 | — | — | EP | disclosed |
| US-6350744-B1 | PYRMIDINE OR PYRIDINE DERIVATIVES; ANTIARTHRITIC AND ANTIINFLAMMATORY AGENTS; CACHEXIA TREATMENT; INTERLEUKIN AND TUMOR NECROSIS FACTOR INHIBITORS | MERCK & CO., INC. | 2002-02-26 | — | — | US | disclosed |
| EP-1131314-A1 | COMPOUNDS HAVING CYTOKINE INHIBITORY ACTIVITY | Merck & Co., Inc. (US) | 2001-09-12 | — | — | EP | disclosed |
| WO-2000031065-A1 | COMPOUNDS HAVING CYTOKINE INHIBITORY ACTIVITY | MERCK & CO., INC. (US) | 2000-06-02 | — | — | WO | disclosed |
| US-5792778-A | TREATMENT OF CYTOKINE MEDIATED DISEASES | MERCK & CO., INC. (US) | 1998-08-11 | — | — | US | disclosed |